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A B S T R A C T
Candida mediastinitis is a rare complication of open heart surgery with high mortality and morbidity
usually associated with C. albicans. We are reporting the case of a 57 year old male who after having a
triple coronary artery bypass graft procedure, had mediastinitis caused by Candida famata, a yeast, that
had only been reported once before as the causal agent of this condition. It is of vital importance, that
future cases be reported, due to the fact that both reported cases have led to patient demise.
ã 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Candida famata (Candida ﬂareri) is a riboﬂavin overproducing
[1], high osmotolerant yeast [2] that produce white to cream
colored colonies on yeast extract peptone dextrose (YPD) medium
(Fig. 1). This organism was considered to be a teleomorph of
Debaryomyces hansenii [3] but was reclassiﬁed via rRNA gene
intergenic spacer ﬁngerprinting as a unique phylogenetic entity
[4].[2_TD$DIFF]
This organism is isolated from many sources, mainly related to
food production. It has been detected in the teats of dairy cows [5],
various types of cheese [6], prawns [7], feral pigeons [8], wild birds
[9] and albino rats [10] among others (Fig. 2).
Infections by this agent are mainly observed in patients with
depressed immune response, it has been identiﬁed as the cause of
neonatal sepsis in a low weight preterm infant [11], oral thrush in
patients with chronic kidney disease [12], peritonitis in patients
with continuous ambulatory peritoneal dialysis [13], invasive
infection in stem cell transplant patients [14], candidemia in
pediatric cancer patients [15]. This pathogen has also been
described as an atypical cause of vaginitis [16], onychomycosis
of the hands and feet [17] and cholecystitis [18].
After an exhaustive literary review utilizing Pubmed and
Ebscohost databases, we were able to ﬁnd one previous report of
mediastinitis by this agent [19].
We present the case of a 57 year old male who was diagnosed
with [7_TD$DIFF]Candida famata mediastinitis after having coronary artery
bypass surgery.
Case report
A 57year old male with a past medical history of type
2 diabetes, hypertension, a 90 pack year history of smoking and
a previous inferior wall myocardial infarction treated with
multiple vessel stent placement who was referred to our hospital
after failing a dobutamine stress test. After admission an
angiography was performed that showed a 90% obstruction of
the distal third of the anterior and posterior descending artery as
well as an 80–90% occlusion of the medial third of the right main
coronary artery. A triple coronary artery bypass grafting (CABG)
with saphenous vein graft was performed 29days after admission,
and a mediastinal drain was left in place. During the procedure it
was noted that the patient’s pericardium was inﬂamed therefore
he was diagnosed with Dressler syndrome. The patient had
multiple post op complications such as a documented cerebral
infarction and a difﬁcult airway 24h post op.
An infected sternotomy site was noted on post op day #7.
During status postop day #13 he went into septic shock that was* Corresponding author.
E-mail address: drsanchez@usanjudas.ac.cr (A.A. Sanchez Betancourt).
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further complicated by acute kidney injury. The patient received a
course of vancomycin and piperacillin-tazobactam, which was
later switched to imipenem. An obvious thickening of the
mediastinum was observed in a chest X-ray and the diagnosis of
post-surgical mediastinitis was made. The patient had multiple
cultures and a chest computerized tomography (CT) was ordered.
The CT revealed small amounts of ﬂuid in the superior mediasti-
num, fat stranding (Figs. 3 and 4 ), as well as reactive inﬂammation
of the precarinal and prevascular lymph nodes, therefore, surgical
drainage via sternotomy was performed.
The patient grew two different species of fungi from different
sources. Candida parapsilosis was identiﬁed in the patient’s urine
and central venous catheter, and Candida famata was retrieved
from the mediastinal drain and the sternotomy wound. Antimi-
crobial sensitivity test was not performed. The patient was given
amphotericin B for 2days, and after the ﬁnal cultures were
obtained, a course of caspofungin was begun. Unfortunately, the
patient had poor therapeutic response, went into multiorgan
failure and expired on day 81 of his stay.
Discussion
Candida mediastinitis is a rare complication of open heart
surgery [20] with high mortality and morbidity. We were able to
identify one previous case report of mediastinitis by [8_TD$DIFF]C. famata, that
patient shared multiple similarities with our patient: coronary
artery bypass grafting, a prolonged hospital stay and a fatal
outcome to the infection.
[3_TD$DIFF] here are multiple chemotherapeutic agents that can be
utilized to treat [9_TD$DIFF]C. famata infections. In vitro studies have shown
that many agents are active against this yeast. The echinocandin
anidulafungin [21] ﬂucytosine, amphotericin B, caspofungin [22]
and posaconazole [23] show the greatest antimicrobial activity.
Resistance to ﬂuconazole [24,25] make it a poor choice as ﬁrst line
treatment. The underlying condition and the source of [5_TD$DIFF]contami-
nation play an important role in the natural progression of the
infection. In the case of mediastinitis, surgical drainage andwound
debridement are critical components to managing this condition
[20].
Due to the rarity of this particular surgical complication, we yet
don’t have a clear understanding as to whether or not this species
of [6_TD$DIFF]Candida requires a different therapeutic approach than themore
common C. albicans. Hopefully in the future, we will have a clearer
picture as to what measures will help reduce mortality in these
patients.
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[(Fig._1)TD$FIG]
Fig. 1. C. famata growth on YPD medium.
[(Fig._2)TD$FIG]
Fig. 2. C. famata observed under light microscopy at 40x via KOH staining.
[(Figs._3and 4)TD$FIG]
Figs. 3 and 4. Fluid level observed on chest CT with thickening of the anterior portion of the superior mediastinum.
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